Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027

  • Report ID:MRHC - 104382
  • Pages: 158
  • Mar 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction
    1.1. Market Definition
    1.2. Market Ecosystem
    1.3. Currency
     1.4. Key Stakeholders

2. Research Methodology
     2.1. Research Process
     2.2. Data Collection & Validation
            2.2.1. Secondary Research
            2.2.2. Primary Research
     2.3. Market Assessment
            2.3.1. Market Size Estimation
                     2.3.1.1. Bottom-Up Approach
                     2.3.1.2. Top-Down Approach
                     2.3.1.3. Growth forecast
            2.3.2. Market Share Analysis
     2.4. Assumptions for the Study
     2.5. Limitations for the Study

3 Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Drivers
            4.2.1. Rising Prevalence of Chronic Diseases
            4.2.2. Development of CLIA-Waived Molecular POC Tests
            4.2.3. Venture Capital Funding for Development of POC Molecular Diagnostics Products
            4.2.4. Growing Demand for POC Molecular Diagnostics
            4.2.5. Need for Rapid Decision Making in Emergency Care Departments

    4.3. Restraints
           4.3.1.Technical Requirements & Regulatory Process for High or Moderate Complexity Tests

   4.4. Opportunity
           4.4.1. Emerging Economies

   4.5. Challenge
           4.5.1. Low Access for Tests Owing to Reimbursement Cuts

5. POC Molecular Diagnostics Market, by Product
    5.1. Introduction
    5.2. Kits & Assays
    5.3. Analyzers
    5.4. Software and Services

6. POC Molecular Diagnostics Market, by Technology
    6.1. Introduction
    6.2. Real-Time Quantitative Polymerase Chain Reaction (Rt-QPCR)
    6.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
    6.4. Other Technologies

7. POC Molecular Diagnostics Market, by Application
    7.1. Introduction
    7.2. Respiratory Diseases
    7.3. Sexually Transmitted Diseases (STDs)
    7.4. Hospital Acquired infections (HAIs)
    7.5. Oncology
    7.6. Neonatal & Prenatal Testing
    7.7. Other Applications

8. POC Molecular Diagnostics Market, by End User
    8.1. Introduction
    8.2. Clinics and Diagnostics Laboratories
    8.3. Hospital Outpatient Departments & Intensive Care Units (ICUs)
    8.4. Research and Academic institute
    8.5. Other End Users

9. POC Molecular Diagnostics Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia Pacific (RoAPAC)
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
       10.1. Introduction
       10.2. Key Growth Strategies
       10.3. Competitive Benchmarking
       10.4. Market Share Analysis

11. Company Profiles
       11.1. Alere Inc. (Subsidiary of Abbott Laboratories)
       11.2. Quidel Corporation
       11.3. F. Hoffmann-La Roche Ltd.
       11.4. Danaher Corporation
       11.5. Thermo Fisher Scientific Inc.
       11.6. Biomérieux SA
       11.7. Meridian Bioscience, Inc.
       11.8. Mesa Biotech Inc.
       11.9. GeneSTAT Molecular Diagnostics, LLC
       11.10. Biocartis Group NV

12. Appendix 
       12.1. Questionnaire
       12.2. Available Customization

List of Tables

Table 1   Global POC Molecular Diagnostics Market: Impact Analysis of Market Drivers (2019–2027)
Table 2   Global Number of New Cancer Cases Among 65 Years and Older (In Millions)
Table 3   WHO Prevalence of Chlamydia, Gonorrhea, Trichomoniasis, and Syphilis, By Region (In %)
Table 4   Some POC Molecular Diagnostic Products with CLIA Waiver
Table 5   Global POC Molecular Diagnostics Market: Impact Analysis of Market Restraint (2019–2027)
Table 6   Few Examples of Moderate or High Complexity POC Molecular Diagnostics Tests
Table 7   Requirements for CLIA Waived, Moderate or High Complexity POC Molecular Diagnostics Tests
Table 8   Global POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 9   Prices of POC Molecular Diagnostic Kits & Assays
Table 10  Key Companies Offering POC Molecular Diagnostic Kits & Assays
Table 11  Pipeline POC Molecular Diagnostic Kits & Assays
Table 12  Global POC Molecular Diagnostic Kits & Assays Market Size, By Country/Region, 2017-2027 ($Million)
Table 13  Key Companies Offering POC Molecular Diagnostic Analyzers
Table 14 Global POC Molecular Diagnostic Analyzers Market Size, By Country/Region, 2017-2027 ($Million)
Table 15 Key Companies Offering POC Molecular Diagnostic Software & Services
Table 16 Global POC Molecular Diagnostic Software and Services Market Size, By Country/Region, 2017-2027 ($Million)
Table 17 Comparison Between RT-qPCR and INAAT
Table 18 Global POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 19 Key Companies Offering RT-qPCR-Based POC Molecular Diagnostics
Table 20 Global RT-qPCR-Based POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
Table 21 Key Companies Offering INAAT-Based POC Molecular Diagnostics
Table 22 Global INAAT-Based POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
Table 23 Global POC Molecular Diagnostics Market Size for Other Technologies, By Country/Region, 2017-2027 ($Million)
Table 24 Global POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million) 
Table 25 Commercialized POC Molecular Diagnostics for Respiratory Diseases
Table 26 Recent Strategic Developments for Respiratory Disease Diagnosis
Table 27 Global POC Molecular Diagnostics Market Size for Respiratory Diseases, By Country/Region, 2017-2027 ($Million)
Table 28 Commercialized POC Molecular Diagnostics for STDs
Table 29 Pipeline POC Molecular Diagnostics for STDs
Table 30 Global POC Molecular Diagnostics Market Size for STDs, By Country/Region, 2017-2027 ($Million)
Table 31 Commercialized POC Molecular Diagnostics for Hospital-Acquired Infections (HAIs)
Table 32 Global POC Molecular Diagnostics Market Size for HAIs, By Country/Region, 2017-2027 ($Million)
Table 33 Commercialized POC Molecular Diagnostics for Oncology
Table 34 Global POC Molecular Diagnostics Market Size for Oncology, By Country/Region, 2017-2027 ($Million)
Table 35 Commercialized POC Molecular Diagnostics for Neonatal & Prenatal Testing
Table 36 Global POC Molecular Diagnostics Market Size for Neonatal & Prenatal Testing, By Country/Region, 2017-2027 ($Million)
Table 37 Commercialized POC Molecular Diagnostic for Other Applications
Table 38 Global POC Molecular Diagnostics Market Size for Other Applications, By Country/Region, 2017-2027 ($Million)
Table 39 Global POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 40 Global POC Molecular Diagnostics Market Size for Clinics and Diagnostic Laboratories, By Country/Region, 2017-2027 ($Million)
Table 41 Key Companies Offering POC Molecular Diagnostics for Hospital-Acquired Infections (HAIs)
Table 42 Global POC Molecular Diagnostics Market Size for Hospital Outpatient Departments and ICUs, By Country/Region, 2017-2027 ($Million)
Table 43 Global POC Molecular Diagnostics Market Size for Research and Academic Institutes, By Country/Region, 2017-2027 ($Million)
Table 44 Global POC Molecular Diagnostics Market Size for Other End Users, By Country/Region, 2017-2027 ($Million)
Table 45 Global POC Molecular Diagnostics Market Size, By Country/Region, 2017-2027 ($Million)
Table 46 North America: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Table 47 North America: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 48 North America: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 49 North America: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 50 North America: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 51 U.S.: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 52 U.S.: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 53 U.S.: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 54 U.S.: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 55 Canada: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 56 Canada: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 57 Canada: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 58 Canada: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 59 Europe: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Table 60 Europe: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 61 Europe: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 62 Europe: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 63 Europe: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 64 Germany: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 65 Germany: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 66 Germany: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 67 Germany: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 68 France: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 69 France: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 70 France: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 71 France: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 72 Italy: Cancer Prevalence Cases, 2010 and 2020
Table 73 Italy: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 74 Italy: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 75 Italy: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 76 Italy: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 77 U.K.: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 78 U.K.: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 79 U.K.: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 80 U.K.: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 81 Spain: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 82 Spain: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 83 Spain: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 84 Spain: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 85 Roe: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 86 Roe: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 87 Roe: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 88 Roe: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 89 Asia-Pacific: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Table 90 Asia-Pacific: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 91 Asia-Pacific: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 92 Asia Pacific: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 93 Asia Pacific: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 94 Japan: POC Molecular Diagnostics Market Size, By Product & Solutions, 2017-2027 ($Million)
Table 95 Japan: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 96 Japan: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 97 Japan: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 98 China: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 99 China: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 100  China: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 101  China: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 102  India: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 103  India: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 104  India: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 105  India: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 106  Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 107  Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 108  Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 109  Rest of Asia-Pacific: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 110  Latin America: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 111  Latin America: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 112  Latin America: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 113  Latin America: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 114  Middle East & Africa: POC Molecular Diagnostics Market Size, By Product & Solution, 2017-2027 ($Million)
Table 115  Middle East & Africa: POC Molecular Diagnostics Market Size, By Technology, 2017-2027 ($Million)
Table 116  Middle East & Africa: POC Molecular Diagnostics Market Size, By Application, 2017-2027 ($Million)
Table 117  Middle East & Africa: POC Molecular Diagnostics Market Size, By End User, 2017-2027 ($Million)
Table 118  Number of Developments by The Major Players During 2016-2020

List of Figures

Figure 1  Research Process 
Figure 2  Key Secondary Sources
Figure 3  Primary Research Techniques
Figure 4  Key Executives Interviewed
Figure 5  Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6  Market Size Estimation
Figure 7  Global POC Molecular Diagnostics Market, By Product & Solution, 2019 Vs. 2027 ($Million)
Figure 8  Global POC Molecular Diagnostics Market Size, By Technology, 2019 Vs. 2027 ($Million)
Figure 9  Global POC Molecular Diagnostics Market Size, By Application, 2019 Vs. 2027 ($Million)
Figure 10  Global POC Molecular Diagnostics Market Size, By End User, 2019 Vs. 2027 ($Million)
Figure 11  POC Molecular Diagnostics Market, By Region 
Figure 12  Market Dynamics 
Figure 13  Global Geriatric Population, 2005-2020 (In Million)
Figure 14  Disposable Personal Income in China (In $)
Figure 15  Percent of Major Disease Groups to Total Disability-Adjusted Life Years (DALYS) In India, 1990 and 2016
Figure 16  Global POC Molecular Diagnostics Market Size, By Product & Solution, 2019-2027 ($Million)
Figure 17  Global POC Molecular Diagnostics Market Size, By Technology, 2019-2027 ($Million)
Figure 18  Global POC Molecular Diagnostics Market Size, By Application, 2019-2027 ($Million)
Figure 19  Global Prevalence of Gonorrhea in Women and Men, 2012 and 2016 (In %)
Figure 20  Global Prevalence of Trichomoniasis in Women and Men, 2012 and 2016 (In %)
Figure 21  Global POC Molecular Diagnostics Market Size, By End User, 2019-2027 ($Million)
Figure 22  U.S. Distribution of Outpatient Vs. Inpatient Revenues, 2010 – 2016
Figure 23  U.S.: Home Healthcare Spending, 2015-2026 ($Billion)
Figure 24  Global POC Molecular Diagnostics Market Size, By Region, 2019-2027 ($Million)
Figure 25  North America: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Figure 26  U.S. Influenza Burden (2010-2018)
Figure 27  U.S. Health Expenditure for Home Health Care (2005-2017) (In $Billion)
Figure 28  Canada: Chlamydia and Gonorrhea Infections Cases (2006-2017)
Figure 29  Europe: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Figure 30  Germany: VRE Infection Data for ICUs and Surgical Departments, By Infection Site, 2010-2016 (%)
Figure 31  France: Percentage of Older People (65 Years and Above), 2010-2050
Figure 32  Asia-Pacific: POC Molecular Diagnostics Market Size, By Country, 2019-2027 ($Million)
Figure 33  China Population Growth Chart
Figure 34  Key Growth Strategies Adopted by Leading Players -2016-2020
Figure 35  POC Molecular Diagnostics: Competitive Benchmarking
Figure 36  Global POC Molecular Diagnostics Market Share, By Key Players, 2018 (%)
Figure 37  Abbott Laboratories: Financial Overview (2018)
Figure 38  Quidel Corporation: Financial Overview (2018)
Figure 39  F. Hoffmann-La Roche Ltd.: Financial Overview (2018)
Figure 40  Danaher Corporation: Financial Overview (2019)
Figure 41  Thermo Fisher Scientific Inc.: Financial Overview (2018)
Figure 42  Biomérieux SA: Financial Overview (2018)
Figure 43  Meridian Bioscience, Inc.: Financial Overview (2019)
Figure 44  Biocartis Group NV: Financial Overview (2018)

COVID-19

We are in the phase of updating this report by analysing the impact of COVID-19 on this market.

Speak with our analysts to know more here

The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13.2% from 2019 to 2027 to reach at $2.39 billion by 2027. Molecular diagnostics has been conducted in the centralized laboratories since many years; however, its few drawbacks like delay in results, high cost of tests, less accuracy, and late disease diagnosis are leading to increase in mortality rate, thereby hindering the growth of this market. Thus, to overcome this, the new field named as point of care molecular diagnostics has emerged. Its ability to provide rapid and accurate results in less than 1-2 hours has helped to increase its adoption in various low-resource settings. The factors such as rising prevalence of chronic diseases, development of CLIA-Waived molecular POC tests, venture capital funding for development of POC molecular diagnostics products, growing demand for POC molecular diagnostics, and rapid decision making in emergency care are expected to propel the growth in the global POC molecular diagnostics market.

Rising Prevalence of Chronic Diseases Associated with Aging Population is Propelling the Growth of POC Molecular Diagnostics Market

As per the data from United Nations, the number of aged people is continuously increasing over the several decades. Such demographic shift is leading to increase in the prevalence of various chronic diseases. For instance, as per the International Journal of Cancer, the number of new cancer cases in the world was 14.1 million in 2012, which is expected to grow 24.4 million by 2035 with China showing the highest number of cancer cases among 65 years and older. This is attributed to the rising number of cancer risk factors, lack of information about their causes, and lack of detection & treatment solutions. Present diagnostic methods for cancer are invasive (for instance, cystoscopy – insertion of a hollow tube/cystoscope equipped with a lens into urethra to bladder for diagnosis of cancer). In such scenario, less invasive methods such as point of care molecular tests may prove effective.

Apart from cancer in aged people, respiratory diseases from small children to adults are becoming one of the top five diseases responsible for deaths. As per the National Institute of Allergy and Infectious Diseases, globally, Respiratory Syncytial Virus (RSV) affects around 64 million people and causes 160,000 deaths each year. Moreover, the WHO predicted that the global burden of RSV-associated acute lower respiratory infection is found to be 33 million annually, resulting in more than 3 million hospitalizations and 59,600 in-hospital deaths in children aged under 5 years. However, there is only 1 vaccine approved for prevention of RSV infections till 2016. There are many vaccines which are still under clinical trials. This increases the cases of death as people are not aware about the available treatment. Thus, the availability of POC molecular diagnostic tests plays an important role in quick analysis and thereby helps in offering immediate treatment to patients.

Click here to: Get Free Request Sample Pages of this report

Key Findings in the Global POC Molecular Diagnostics Market Study:

RT-qPCR Segment Dominated the POC Molecular Diagnostics Market in 2019

The factors such as large number of commercially available RT-qPCR based POC molecular diagnostic systems or tests compared to other technologies, use of RT-qPCR in proteomics & genomics, and need for rapid diagnosis of viral & infectious diseases are contributing to the largest share of this segment.

Kits & Assays Segment to Grow at the Fastest CAGR During the Forecast Period

Kits & Assays are essential components during any laboratory procedure. Its frequent use in the molecular diagnostic testing resulted into its higher volume and value share. Apart from this, growing prevalence of chronic diseases resulted into technological advancements by the key market players to expand their product portfolio of disease specific assays for early diagnosis. In addition, growing focus of key market players on receiving CLIA approval further support the fastest growth of kits & assays segment.

Respiratory Diseases Held the Largest Share of the POC Molecular Diagnostics Market in 2019

The respiratory diseases segment dominated the POC molecular diagnostics market in 2019. The factors such as increasing number of respiratory & associated infectious diseases, large number of commercialized POC molecular diagnostic products for respiratory disease diagnosis, and focus of key market players on adopting various strategies for commercializing or developing advanced POC molecular diagnostic products contribute to the largest share of this application segment.

Asia Pacific: The Fastest Growing Market

At regional level, the overall POC molecular diagnostics market is dominated by North America in 2019, while, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of Asia Pacific POC molecular diagnostics market are rising incidences of chronic diseases associated with geriatric population, expansion of key market players in this region, insufficient sophisticated central laboratory testing services, and potential cost effectiveness of POC molecular diagnosis.

Key Players

The report includes competitive landscape based on the extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the industry over the past 5 years (2016-2020). The key players profiled in the global POC molecular diagnostics market are Alere Inc. (U.S.), DxNA, LLC. (U.S.), Mesa Biotech Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Danaher Corporation (U.S.), Quidel Corporation (U.S.), Biocartis Group NV (Belgium), bioMérieux SA (France), Thermo Fisher Scientific (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland).

Scope of the Report:

Market by Product & Solution

  • Kits & Assays
  • Analyzers
  • Software & Services

 Market by Technology

  • Real-Time Polymerase Chain Reaction (RT-qPCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Other Technologies

 Market by Application

  • Respiratory Diseases
  • Sexually Transmitted Diseases (STDs)
  • Hospital Acquired Infections (HAIs)
  • Cancer/Oncology
  • Prenatal/Neonatal Testing
  • Other Applications

Market by End User

  • Clinics and Diagnostic Laboratories
  • Hospital Outpatient Departments and Intensive Care Units (ICUs)
  • Research and Academic Institutes
  • Other End Users

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa

Key questions answered in the report-

Kits & Assays accounted for the largest share of the point of care molecular diagnostics market

  • What factors are contributing to the huge demand for kits & assays across the region?
  • How does the adoption of kits & assays differ from other products?

Clinics and diagnostic laboratories accounted for the largest share of the point of care molecular diagnostics market

  • What factors contribute to the frequent usage of overall point of care molecular diagnostics products in clinics and diagnostic laboratories?
  • Which geographic segment is expected to experience the fastest growth in the usage of point of care molecular diagnostics products in clinics and diagnostic laboratories?
  • How does the penetration of point of care molecular diagnostics products differ from other end users such as hospital outpatient departments and intensive care units (ICUs)?

The point of care molecular diagnostics market favors both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What factors are driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies look to enter this market use to compete effectively?
  • What are the major drivers, restraints, opportunities, and challenges in the point of care molecular diagnostics market?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Molecular Diagnostics In Vitro Diagnostics
Download Free Sample